PHPSX
Price
$24.45
Change
-$0.52 (-2.08%)
Updated
Nov 13 closing price
Net Assets
3.22M
RYVYX
Price
$705.94
Change
-$30.24 (-4.11%)
Updated
Nov 13 closing price
Net Assets
1.56B
Interact to see
Advertisement

PHPSX vs RYVYX

Header iconPHPSX vs RYVYX Comparison
Open Charts PHPSX vs RYVYXBanner chart's image
ProFunds Pharmaceuticals UltraSector Svc
Price$24.45
Change-$0.52 (-2.08%)
VolumeN/A
Net Assets3.22M
Rydex NASDAQ-100® 2x Strategy H
Price$705.94
Change-$30.24 (-4.11%)
VolumeN/A
Net Assets1.56B
PHPSX vs RYVYX Comparison Chart in %
View a ticker or compare two or three
VS
PHPSX vs. RYVYX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHPSX is a Buy and RYVYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.56B vs. PHPSX (3.22M). PHPSX (0.00) and RYVYX (0.00) have matching dividends . PHPSX was incepted earlier than RYVYX: PHPSX (25 years) vs RYVYX (25 years). PHPSX (3.50) is less costly to investors than RYVYX (1.87). RYVYX is a more actively managed with annual turnover of: 383.00 vs. PHPSX (207.00). RYVYX has a lower initial minimum investment than PHPSX: RYVYX (2500) vs PHPSX (15000). RYVYX annual gain was more profitable for investors over the last year : 24.71 vs. PHPSX (4.61). RYVYX return over 5 years is better than : 136.30 vs. PHPSX (10.54).
PHPSXRYVYXPHPSX / RYVYX
Total Expense Ratio2.781.74160%
Annual Report Gross Expense Ratio3.501.87187%
Fund Existence25 years25 years-
Gain YTD21.86433.75865%
Front LoadN/AN/A-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets3.22M1.56B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.6124.7119%
Returns for 3 years12.78228.736%
Returns for 5 years10.54136.308%
Returns for 10 years19.36844.522%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY1.130.05
+5.09%
Oncolytics Biotech
RL340.216.43
+1.93%
Ralph Lauren Corp
FOLD9.420.10
+1.07%
Amicus Therapeutics
ADTN8.040.01
+0.12%
ADTRAN Holdings
CENN0.17N/A
-0.63%
Cenntro